SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MorphoSys AG (MOR)
An SI Board Since January 2000
Posts SubjectMarks Bans
421 15 0
Emcee:  michael_f_murphy Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
146MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment; TecDAX) hanigel bates-3/29/2006
145MorphoSys and Japanese Pharmaceutical Group Daiichi Sankyo Form Broad Alliance tnigel bates-3/16/2006
144West LB Upgrades MorphoSys To Buy Tuesday, March 14, 2006 5:56:27 AM ET Dow JoGermanecki-3/15/2006
143Morphosys Shares Playing Catch Up -Traders Tuesday, March 14, 2006 5:41:18 AM Germanecki-3/15/2006
142pharmaceutical business review: MorphoSys and Roche collaborate on oncology therGermanecki-3/3/2006
141WestLB: Keeps at add, Lowers MorphoSys Target to 54,50 Wednesday, March 01, 200Germanecki-3/1/2006
140MorphoSys and Roche Expand Therapeutic Antibody Partnership Wednesday March 1, 2nigel bates-3/1/2006
139The latter, I'm afraid. :-)nigel bates-2/28/2006
138Good afternoon, Nigel, and, if I may ask, did you get back in to MorphoSys afterquidditch-2/28/2006
137MorphoSys Achieves Fourth Therapeutic Milestone in Centocor Collaboration Tuesdanigel bates-2/28/2006
136MorphoSys AG Reports Financial Results for Fiscal Year 2005 Martinsried/Munich,Germanecki-2/24/2006
135Morphosys Tumbles After Dumping Compounds Friday, February 24, 2006 4:44:58 AMGermanecki-2/24/2006
134MorphoSys Updates Strategy for Proprietary Product Development Friday February 2nigel bates-2/24/2006
133In Germany we call it the move! :-) bigcharts.marketwatch.comGermanecki-2/13/2006
132WestLB Lifts MorphoSys Target Price Monday, February 06, 2006 5:43:22 AM ET DoGermanecki-2/6/2006
131Preliminary Financial Results: revenues 33.5(22.0), net incom 4.7(0.3) <b>Germanecki-2/3/2006
130US-Investors seem not to be interested in Biotecs with profits? There are no trGermanecki-1/28/2006
129Excellent outlook! outbreak bigcharts.marketwatch.comGermanecki-1/26/2006
128Roche Plans Clinical Trial with MorphoSys-Generated Alzheimer Antibody Press ReGermanecki-1/25/2006
127MorphoSys Boosts Antibody Work With $35M Acquisition By Jennifer Boggs StaffGermanecki-1/18/2006
126This was sent today to the customers of serotec and oxford biotechnology: SEROTGermanecki-1/18/2006
125Morphosys Buy Makes Strategic Sense Thursday, January 12, 2006 4:56:50 AM ET DGermanecki-1/12/2006
124MorphoSys Acquires Serotec Group to Strengthen Global Research Antibody Businessnigel bates-1/12/2006
123Reuters UPDATE 1-MorphoSys signs antibody deal with Chemicon Tue Jan 10, 2006 0Germanecki-1/10/2006
122MorphoSys Establishes American Depository Receipt Level One Program in USA 07:Germanecki-1/10/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):